Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis.

Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis. Abstract Text:

,

Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis. Publishing Authors By Initials

,

For similar human activities: travel research abstracts see: human activities: travel research

PUBMED ID PMID:

MEDLINE DATE:

Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: MMWR. Morbidity and mortality weekly report

VOLUME: 35

Page Numbers: 165-6

Journal Abbreviation: MMWR Morb. Mortal. Wkly. Rep.

ISSN: 0149-2195

DAY: 14

MONTH: Mar

YEAR: 1986

Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7802429

Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis. Keywords Mesh Terms:

KEYWORDS: Travel

MESH TERMS: adverse effects

Chemical & Substance for Abstract: Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis. Information

Substance Name: Amodiaquine

Registry Number: 86-42-0

Grant and Affiliation Information for Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: MMWR Morb Mortal Wkly Rep

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Agranulocytosis associated with the use of amodiaquine for malaria prophylaxis Related Publications